Deal snapshot: Ligand Pharmaceuticals Acquires Assets of Novan for USD 12.2m.

MANews-(C)2009-2023

US-based biopharmaceutical company Ligand Pharmaceuticals Inc. (NASDAQ: LGND) has acquired all assets of North Carolina-based medical dermatology company Novan, Inc. for USD 12.2m, the company said.

Ligand offered USD 15m to acquire all of the assets of Novan as well as to provide up to USD 15m in debtor-in-possession financing. In September 2023, the Bankruptcy Court...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT